| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189392 | Brachytherapy | 2014 | 7 Pages |
Abstract
CT/MRI is more precise than CT for prostate volume delineation and dosimetric quality assessment and thus provides superior heterogeneity control assessment after 103Pd monotherapy implants.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Vinita Takiar, Thomas J. Pugh, David Swanson, Rajat J. Kudchadker, Teresa L. Bruno, Sarah McAvoy, Usama Mahmood, Steven J. Frank,